Skip to main content
Article
Myeloablative Busulfan/Melphalan Consolidation following Induction Chemotherapy for Patients with Newly Diagnosed High-Risk Neuroblastoma: Children's Oncology Group Trial ANBL12P1
Transplantation and Cellular Therapy
  • Joseph Panoff, Miami Cancer Institute
Publication Date
6-1-2021
Content Type
application/pdf
PubMed ID:
33823167
Additional Authors:

Additional authors and institutional affiliations

Citation Information

Transplant Cell Ther (2021) 27(6).